What we do
Equity products
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
Pan-European Venture Capital Fund(s)-of-Funds programme
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
Debt products
AGRI Guarantee Facility
AGRI Italy Platform Uncapped Guarantee Instrument
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
EREM debt products
Single EU Debt Financial Instrument
COSME - Loan Guarantee Facility
InnovFin SME Guarantee Facility
Documentary Finance Facility – Bulgaria
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
Asset Management Umbrella Fund (AMUF)
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
AGRI Italy Platform Uncapped Guarantee Instrument
ALTER’NA – ESIF EARFD Nouvelle-Aquitaine
Baltic Innovation Fund (BIF)
Central Europe Fund of Funds (CEFoF)
Croatian Venture Capital Initiative (CVCi FoF)
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
Dutch Growth Co-Investment Programme
Dutch Venture Initiative (DVI-II)
EAFRD FoF Romania
European Recovery Programme (ERP)
ERP-EIF Co-Investment Growth Facility
Competitiveness Fund-of-Funds for SMEs in Romania
Regional Fund-of-Funds Romania
ESIF Fund-of-Funds Czech Republic
ESIF Fund-of-Funds Greece
The Silesia EIF Fund of Funds
La Financière Région Réunion
The EIB Group Risk Enhancement Mandate (EREM)
EstFund
FOSTER TPE-PME Occitanie
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
JEREMIE
LfA-EIF Facility
Luxembourg Future Fund (LFF)
Mezzanine 'Fund of Fund' for Germany (MDD)
Polish Growth Fund of Funds (PGFF)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Western Balkans Enterprise Development & Innovation Facility (WB EDIF)

Kotziamanis Biodiagnostics: improving medical imaging

image

“When you’re dealing with people’s lives, you want to be able to offer the best services possible” says Dr. Andreas Kotziamanis, who runs Kotziamanis Diagnostics in Limassol, Cyprus, alongside his daughter Natasa. “It’s very much a family business. My daughter has specialised in breast cancer and we’re expecting my son Alexandros to join us when he completes his studies next year.”

Kotziamanis Diagnostics is a diagnostic centre specialising in medical imaging and interventional radiology. The centre attaches great importance to constantly evolving with technology to offer the best services to its patients, doctors and the healthcare institutions it works with. “We recently replaced all analogue equipment with new digital equipment, providing higher image quality with the lowest possible radiation dose to the patient” explains Dr. Kotziamanis, “and we set up an information system that allows efficient management of medical images and remote data access. We are constantly upgrading our medical imaging devices, improving our information systems, our software and investing in cybersecurity. After all, this is sensitive personal data.”

A recent upgrade to the centre has been the addition of an MRI scanner to help with breast cancer diagnosis and treatment. “This new machinery will improve diagnostic accuracy. It will give us a more complete picture and allow us to detect tiny tumours much earlier” explains Dr. Kotziamanis.

To cover the costs of the new machinery, Dr. Kotziamanis turned to Ancoria Bank, who extended a loan at favourable conditions with the backing of EIF. “It makes it affordable, and allows us to keep our prices as low as possible.” Two new employees have since been hired to manage the new machinery.

Looking ahead, Dr. Kotziamanis is committed to continue the automatization of the centre’s work, integrating supply chain management and accounting into the digitised systems, making the flow of information as efficient and smooth as possible, and even considering a central island-wide information-sharing platform in collaboration with other healthcare professionals. “At the end of the day, the better the system works, the stronger our position when we try to save lives” concludes Dr. Kotziamanis.

Company: Kotziamanis Biodiagnostics (Cyprus)

Type of business: Medical devices / Medicine

EIF financing: CYPEF

Financial intermediary: Ancoria Bank

For further information about EIF intermediaries in Cyprus, please refer to: http://www.eif.org/what_we_do/where/cy


 
 

Copyright ©

 European Investment Fund 2019 – The European Investment Fund is not responsible for the content of external internet sites.